Vikram M. Narayan

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Clinical Sciences, Oncology +8

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 442 citations · Full text

Medicine, Oncology, Urology +13

A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer

Marius Goldkuhle, Vikram M. Narayan, Aaron Weigl et al. · BMJ Open · 2018 · 90 citations · Full text

Public Health, Clinical Sciences, Oncology +17

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar et al. · The Journal of Urology · 2024 · 75 citations · Full text

Medicine, Oncology, Urology +9

Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design

Justin T. Matulay, Roger Li, Patrick J. Hensley et al. · The Journal of Urology · 2021 · 69 citations

Medicine, Oncology, Urology +7